(Vienna, 15 January 2026) – Georg Hansmann has been appointed to the Professorship of Paediatric Cardiology (§98) at the Medical University of Vienna. At the same time, he takes over as head of the Clinical Division of Pediatric Cardiology, Pediatric Heart Centre Vienna, Department of Pediatrics and Adolescent Medicine at AKH and MedUni Vienna. With this appointment, MedUni Vienna is strengthening paediatric cardiology at the University Hospital Vienna. Working in close collaboration with the Department of Cardiac and Thoracic Aortic Surgery and other partner disciplines, the aim is to further develop the existing Pediatric Heart Centre Vienna into an internationally renowned institution, dedicated to outstanding patient care, translational research, and innovative teaching.
Clinically, Georg Hansmann specialises in the management of congenital heart defects and rare cardiopulmonary and vascular conditions – spanning prenatal diagnostics, novel interventional and surgical therapies, cutting-edge pharmacological approaches, and heart or lung transplantation. A particular translational focus is on the development and first-in-human application of regenerative strategies, including therapy using umbilical cord–derived mesenchymal stem cells.
Through the establishment of the new Centre for Pulmonary Hypertension, Heart Failure and Transplantation, Georg Hansmann is placing renewed emphasis on comprehensive care for paediatric patients at University Hospital Vienna, from newborns to young adults. In parallel, he is launching the Translational Cardiovascular Biomedicine programme, integrating four core research areas: regenerative medicine, immunomodulation and transplantation, vascular biomedicine, and congenital heart defects. The overarching goal is to develop innovative therapies for conditions that were previously fatal or considered incurable.
Georg Hansmann also plans to make a significant impact in medical education, by introducing structured fellowship programmes, fostering international exchange for clinician-scientists, and enabling early, longitudinal involvement of medical students in the care of children with cardiovascular disease.
“I am very pleased to now be implementing these plans at a leading centre such as MedUni Vienna and the University Hospital Vienna, together with my team and colleagues from other disciplines,” said Georg Hansmann.
About Georg Hansmann
Georg Hansmann grew up in the Düsseldorf region and studied medicine in Freiburg, where he also completed his doctorate in pharmacology on vascular P2 receptors. Following clinical training in Berlin and Munich, he spent more than eight years in leading clinical and scientific roles at major universities in the United States (UC San Francisco, Stanford, and Harvard University). In 2010, he completed his postdoctoral thesis (habilitation) at Charité – Universitätsmedizin Berlin.
Upon returning to Germany, he spent 11 years at the Department of Paediatric Cardiology and Critical Care at Hannover Medical School (MHH), Germany, most recently as Senior Consultant. In January 2024, he joined the Disivision of Paediatric Cardiology at Friedrich-Alexander University (FAU) Erlangen-Nuremberg. Since May 2024, he has served as a Visiting Professor at Harvard Medical School in Boston, and since November 2025 he has been a translational group leader at Tübingen University Hospital.
Georg Hansmann and his team members have received numerous national and international awards for their clinical and scientific achievements, including the Cournand & Comroe Prize from the American Heart Association, the SPR Research Award from the Society for Paediatric Research, the Werner Forßmann Prize from the University of Bochum, and the AEPC Best Paper Award from the Association for European Paediatric and Congenital Cardiology. Since 2014, his research has been continuously funded by the German Research Foundation (DFG), and other agencies.